Try our Advanced Search for more refined results
May 09, 2022
Gilead Sciences, Inc. v. Lupin Ltd. et al
Case Number:
1:22-cv-00615
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 10, 2022
Gilead Slaps Rivals With Patent Suit Over HIV Drug
Gilead Sciences Inc. has initiated a drug patent suit against a trio of competitors in Delaware federal court, seeking to block three generic versions of its human immunodeficiency virus treatment Biktarvy.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login